A. Shenoy

The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy

Rasheed Zakaria, Daniel Crooks, Atik Baborie, 2016, Acta Neurochirurgica.

PO69THE IMPACT OF MGMT METHYLATION AND IDH-1 MUTATION ON LONG TERM OUTCOME FOR GLIOBLASTOMA TREATED WITH CHEMORADIOTHERAPY

A. Brodbelt, M. Jenkinson, D. Husband, 2015 .

Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach

T. Helliwell, M. Robinson, N. Roland, 2016, Head & neck.

Transoral laser microsurgery and radiotherapy for oropharyngeal squamous cell carcinoma: Equitable survival and enhanced function compared with contemporary standards of care.

T. Helliwell, K. Milinis, N. Roland, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy.

M. Jenkinson, D. Husband, B. Haylock, 2011, European journal of cancer.

Voice outcomes for early laryngeal cancer

A. Kinshuck, T. Jones, A. Shenoy, 2017, Current opinion in otolaryngology & head and neck surgery.

Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma

P. Warnke, M. Jenkinson, D. Husband, 2010, Journal of Neuro-Oncology.

Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.

N. Fleeman, M. Richardson, Y. Dundar, 2020, Health technology assessment.

A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine

N. Fleeman, Y. Dundar, J. Greenhalgh, 2019, BMC Cancer.

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

A. Brodbelt, T. Liloglou, D. Crooks, 2009, British Journal of Cancer.